Hadassah

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

Monday, May 7 2018

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

Hadassah Pediatric Cardiologist Dr. Julius Golender, who heads surgical evaluation at Hadassah Hospital Ein Kerem, joined doctors from Baruch Padeh and the IDF’s Good Neighbor program in Tiberias, where Syrian mothers had brought their children from Syria. The doctors examined the 17 children and teenagers, ascertained what treatment, if any, they were receiving in Syria, and then determined that 14 of them could benefit from heart surgery at Hadassah.

Dr. Golender explains: "We will make an initial diagnosis and build a treatment plan for any child or teenager who needs cardiac intervention, whether catheterization or surgery, at Hadassah Hospital.” The children are suffering from a wide variety of significant heart abnormalities, according to Dr. Golender,  including ventricular defects and transposition of the great arteries. Their chances of surviving without medical intervention are slim.

 “Made possible by financial support from the Peres Center for Peace, this special cooperation between Hadassah and Baruch Padeh,” relates Dr. Golender, “is important and will save the lives of these children. Hadassah will make use of our Pediatric Cardiac Surgery Department and the indispensable Pediatric Intensive Care Unit for this special humanitarian project. While the children, some of whom have never been properly treated or examined, will come to Jerusalem for the complex surgery and catheterizations at Hadassah, they will receive follow-up care at the Baruch Padeh Medical Center in Tiberias.”

Learn more about the Hadassah Medical Organization.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More